# A Study of Pegmolesatide of in Dialysis Chronic Kidney Disease (CKD) Patients With Anemia Treated With Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI)

> **NCT07136792** · NA · RECRUITING · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 96 (estimated)

## Conditions studied

- Renal Anemia of Chronic Kidney Disease

## Interventions

- **DRUG:** Pegmolesatide 2mg SC
- **DRUG:** Pegmolesatide 4mg SC
- **DRUG:** Pegmolesatide 4mg SC
- **DRUG:** Pegmolesatide 6mg SC

## Key facts

- **NCT ID:** NCT07136792
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-08
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07136792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07136792, "A Study of Pegmolesatide of in Dialysis Chronic Kidney Disease (CKD) Patients With Anemia Treated With Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI)". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT07136792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*